{"disease":{"id":"nasopharyngeal-carcinoma","name":"nasopharyngeal carcinoma"},"drugs":{"marketed":[{"drug_id":"toripalimab","indication_name":"metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loqtorzi","generic_name":"TORIPALIMAB","company_name":"Coherus Biosciences Inc","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"Programmed Death Receptor-1 Blocking Antibody [EPC]","quality_score":10,"revenue":null,"mechanism":"Loqtorzi blocks the PD-1 receptor, allowing the immune system to recognize and attack cancer cells."},{"drug_id":"penpulimab","indication_name":"Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Penpulimab kcqx","generic_name":"PENPULIMAB","company_name":"Akeso Biopharma","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"","quality_score":50,"revenue":null,"mechanism":"Penpulimab works by binding to the PD-1 protein on immune cells, blocking its interaction with the PD-L1 protein on cancer cells and allowing the immune system to attack the cancer."},{"drug_id":"penpulimab","indication_name":"Metastatic Non-Keratinizing Nasopharyngeal Carcinoma with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Penpulimab kcqx","generic_name":"PENPULIMAB","company_name":"Akeso Biopharma","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"","quality_score":50,"revenue":null,"mechanism":"Penpulimab works by binding to the PD-1 protein on immune cells, blocking its interaction with the PD-L1 protein on cancer cells and allowing the immune system to attack the cancer."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06870435","title":"Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas","phase":"NA","overall_status":"RECRUITING","enrollment_count":68649,"lead_sponsor_name":"Ming-Yuan Chen","has_results":false},{"nct_id":"NCT05627310","title":"Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images","phase":"","overall_status":"UNKNOWN","enrollment_count":50000,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT04085900","title":"Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City","phase":"","overall_status":"RECRUITING","enrollment_count":40000,"lead_sponsor_name":"Zhongshan People's Hospital, Guangdong, China","has_results":false},{"nct_id":"NCT05884983","title":"Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Zhongshan People's Hospital, Guangdong, China","has_results":false},{"nct_id":"NCT05447169","title":"Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening","phase":"","overall_status":"RECRUITING","enrollment_count":11625,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT00341146","title":"Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)","phase":"","overall_status":"COMPLETED","enrollment_count":6490,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07072143","title":"An International Study on Pediatric Patients With Rare Tumors.","phase":"","overall_status":"RECRUITING","enrollment_count":6250,"lead_sponsor_name":"Azienda Ospedaliera di Padova","has_results":false},{"nct_id":"NCT04108338","title":"Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":5448,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06129201","title":"Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05682703","title":"A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07088861","title":"Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1401,"lead_sponsor_name":"Lirong Wu","has_results":false},{"nct_id":"NCT06348485","title":"Massive Nasal Bleeding in Patients With NPC Received Curative RT","phase":"","overall_status":"COMPLETED","enrollment_count":1327,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT03529279","title":"CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1324,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05949749","title":"A Retrospective Study Reveals the Relationship Between gp42-IgG Epitopes and EBV-associated NPC","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03290001","title":"The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05517135","title":"tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Cancer Centre, Singapore","has_results":false},{"nct_id":"NCT03855020","title":"Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06445088","title":"Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":908,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04764149","title":"Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":801,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07137052","title":"Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":732,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT03981224","title":"The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients","phase":"","overall_status":"COMPLETED","enrollment_count":706,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT06763289","title":"Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05858385","title":"Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","has_results":false},{"nct_id":"NCT06900218","title":"PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":664,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04890522","title":"An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":622,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05183724","title":"Ovarian Function of Nasopharyngeal Carcinoma Women Survivors","phase":"","overall_status":"UNKNOWN","enrollment_count":602,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06239727","title":"Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":593,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT01365169","title":"Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients\"","phase":"NA","overall_status":"RECRUITING","enrollment_count":590,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06675214","title":"Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":586,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04094545","title":"Intestinal Flora Sequencing for Nasopharyngeal Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":568,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT03346109","title":"To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":568,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04414566","title":"Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":562,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT04907370","title":"PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":532,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06282497","title":"Xerostomia-optimised IMRT Versus Standard IMRT in NPC","phase":"NA","overall_status":"RECRUITING","enrollment_count":524,"lead_sponsor_name":"Zhongshan People's Hospital, Guangdong, China","has_results":false},{"nct_id":"NCT05099978","title":"Asian Multicenter Prospective Study of ctDNA Sequencing","phase":"","overall_status":"UNKNOWN","enrollment_count":506,"lead_sponsor_name":"National Cancer Center, Japan","has_results":false},{"nct_id":"NCT06092957","title":"Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":504,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03942380","title":"Cell-free Tumor DNA in Head and Neck Cancer Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Christian von Buchwald","has_results":false},{"nct_id":"NCT06136962","title":"Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT05587374","title":"Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":490,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06032767","title":"Prospective Observational Study to Predict Severe Oral Mucositis Associated With Chemoradiotherapy in Nasopharyngeal Carcinoma Based on Deep Learning","phase":"","overall_status":"UNKNOWN","enrollment_count":480,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06095167","title":"Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":476,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06095154","title":"CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":474,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT07268690","title":"Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":474,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06775756","title":"Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":474,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06752239","title":"Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":474,"lead_sponsor_name":"Jiangxi Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT03010150","title":"Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":471,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04387266","title":"To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC","phase":"","overall_status":"COMPLETED","enrollment_count":471,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT05983432","title":"Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"SystImmune Inc.","has_results":false},{"nct_id":"NCT06241612","title":"Individualized Elective Neck Irradiation in NPC Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}